Company Filing History:
1 out of 495 
1 out of 258 Years Active: 2022
Title: Sheila K Singh: Innovator in Cancer Research
Introduction
Sheila K Singh is a prominent inventor based in Hamilton, Canada. She has made significant contributions to the field of cancer research through her innovative work on CD133-binding agents. Her research focuses on the detection and quantification of CD133-expressing cells, which play a crucial role in cancer progression.
Latest Patents
Sheila K Singh holds a patent for her invention titled "CD133-binding agents and uses thereof." This patent is directed towards novel CD133-binding agents that can be utilized for various applications, including detecting CD133-expressing cells, targeting these cells, and decreasing CD133 levels in such cells. The implications of her work are significant for the treatment and prevention of cancer.
Career Highlights
Throughout her career, Sheila has worked with esteemed institutions such as the University of Toronto and McMaster University. Her research has garnered attention for its potential to advance cancer therapies and improve patient outcomes.
Collaborations
Sheila has collaborated with notable colleagues, including Jason Moffat and Jarrett Adams, to further her research initiatives. These collaborations have enriched her work and contributed to the development of innovative solutions in cancer treatment.
Conclusion
Sheila K Singh's contributions to cancer research through her patented innovations highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in cancer detection and treatment.